If youre bullish on oil, then Continental Resources (CLR) is the stock for you. I believe the company will likely significantly grow its earnings in 2018 due to higher realized prices and around 20% production growth. Meanwhile the company, which burned cash flows in 2017, will likely report str
Related SPCB Earnings Scheduled For March 29, 2016 Mid-Afternoon Market Update: Oramed Jumps Following Announcement of up to $50M Licensing, Investment Deal in China; Supercom Shares Dip
Related SVA Stocks Hitting 52-Week Highs Sinovac Biotech Ltd. Stock Surged Amid 'Hostile Takeover' Simavita to Integrate....More>>>
U.S. Treasuries suffered their worst month since 2009 as investors fret President-elect Donald Trump’s policies will spell bad news for debt investors and also brace for hikes in short-term interest rates by the Federal Reserve.
The SPDR Bloomberg Barclays Aggregate Bond fund, which tracks the broad bond market, has dropped 2.7% this month in its worst monthly performance since the....More>>>
Don’t give up the ship. Those were Jim Cramer’s words to his Mad Money viewers Wednesday, as he pleaded with those looking to sell to hold onto their shares for a little while longer. Cramer said there are a number of great companies that investors gave up on, and that lack of conviction ended up being very costly.
First up, PPG Industries (PPG) , a stock that was seemingly caught....More>>>
QI want to give my required minimum distribution from my IRA to several charities. What steps do I need to take so that Im not taxed on the RMD? Is there a minimum amount I can transfer or a limit to the number of charities I can send the money to?
SEE ALSO: How to Report a Tax-Free Transfer From an IRA to Charity A
People older than 70陆 can transfer up to $100,000 per year from....More>>>
Last week, women’s clothing retailer The Limited announced it was closing down all of its stores. It’s yet another casualty in the war on shopping malls and highlights the further transition of clothing retail to “fast fashion” and online formatting. It has been an ominous year for brick-and-mortar stores, but another one down could be good news for the survivors.
Evercore ISI’s James West and team explain whyHalliburton (HAL) remains their “North American Winner” among oil-field-services stocks:
A Structural Favorite. Halliburton remains one of our favorite stocks in the group and the management team’s relentless pursuit of efficiency and aggressive positioning for the upcycle will likely make....More>>>
On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap data storage systems stock Qualstar Corporation (NASDAQ: QBAK):
Quelstar is essentially a mirror image of Pixelworks. That is, it’s not just the bearish undertow we want to tap into here. It’s the failure of QBAK to follow-through on today’s effort to break above the 100-day moving average line....More>>>
Whole Foods Market (NASDAQ:WFM) has had a bad time on the market over the past couple of months, losing over 16% of its value on the back of a weak financial performance in its last reported quarter. But, in my opinion, the recent drop in Whole Foods’ shares is an opportunity to buy more of the stock since there are tangible improvements being witnessed across Whole Foods’ operations....More>>>
With July 4th weekend upon us, here were the top 10 stocks with the highest social chatter and sentiment changes this week according to Stockal. Stockal tracks ratings and social data to gauge total sentiment on a stock. Keep an eye out for movement in this stocks next week as well.
1. Atlas Resource Partners, L.P. (NYSE: ARP) – ARP recorded a huge surge in price on Thursday.....More>>>
Money Morning Director of Technology & Venture Capital Research Michael Robinson is still a big fan of Bitcoin and many of the other cryptocurrencies out there. But he acknowledges that they are not for everyone.
Shares of Kura Oncology (KURA) have risen by more than 90% since I presented the idea to readers in September of last year. The stock has climbed 38% since my update piece published in late November in which I stated my expectations of continued upside due to multiple clinical catalysts in 2018